FierceBiotech

ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections

The big-time BARDA contracts keep rolling in, this time for infectious disease biotech and Merck partner ModeX Therapeutics. The company has hauled in a $168 million contract from the Biomedical ...
Seeking Alpha

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed Development ...
Yahoo Finance

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKO Dr. Gary Nabel, ModeX President and CEO, former Chief ...
Seeking Alpha

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (OPK) company, has been awarded a contract from the Biomedical Advanced Research and Development ...
Nasdaq

ModeX Therapeutics Establishes Scientific Advisory Board to Enhance Development of Multispecific Antibodies for Complex Diseases

ModeX Therapeutics Inc., an OPKO Health company, announced the formation of a Scientific Advisory Board to support the development of its immunology and oncology pipeline, which includes ...
Morningstar

MODEX-The Biggest Manufacturing and Supply Chain Event of 2026 is Coming to Atlanta April 13-16

In-person event to feature over 1,000 exhibitors, 200 sessions and keynotes from Home Depot CFO Richard McPhail, Salim Ismail and Dale Earnhardt Jr When the largest manufacturing and supply chain ...